Lungs News and Research

RSS

Inflammation is a strong risk factor for cardiovascular disease among rheumatoid arthritis patients

Mayo Clinic epidemiologists have found that the systemic inflammation characterizing rheumatoid arthritis may be to blame for the increased risk of cardiovascular death in patients with the disease.

3 Mar 2005

Researchers identify first known mutation to occur in lung cancer patients who have never smoked

Dr.Adi Gazdar, professor of pathology in the Nancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and senior author of the study in today's issue of the Journal of the National Cancer Institute, explains that the findings may show why certain lung cancer patients respond dramatically to a specific form of targeted therapy while others have little or no response.

2 Mar 2005

Molecule from South American tree Quillaja, helps battle disease

The first synthesis of QS-21A, a medicinally important molecule that helps the body battle disease, has been achieved by chemists at the University of Illinois at Urbana-Champaign.

1 Mar 2005

African-Americans receive less aggressive treatment for heart attack than whites

According to a study at the Maya Angelou Research Center on Minority Health at Wake Forest University Baptist Medical Center, African-Americans continue to receive less aggressive treatment for heart attack than whites.

1 Mar 2005

Study describes the first known mutation to occur in lung cancer patients who have never smoked

Lung cancer patients who have never smoked are more likely than smokers to harbor one of two genetic mutations that researchers at UT Southwestern Medical Center have now linked to the disease.

1 Mar 2005

Nature’s most sophisticated biological weapon

Nature’s most sophisticated biological weapon, snake venom, largely evolved from bits of body parts a Melbourne researcher has found.

1 Mar 2005

Diesel engines are posing a serious threat to public health

Air particles emitted mainly by diesel engines are posing a serious threat to public health, warn respiratory physiotherapists in a new report published by the Chartered Society of Physiotherapy (CSP).

1 Mar 2005

Cells can regenerate without becoming "younger"

It has long been thought that cells that regenerate tissue do so by regressing to a developmentally younger state. Now two University of Washington researchers have demonstrated that cells can regenerate without becoming "younger."

1 Mar 2005

Scientists find protein that could unlock the secret to more effective treatment of TB

In a study published on 1st March 2005 in Nature Structural & Molecular Biology, a combined team discovered the structure of a protein known as resuscitation promoting factor (Rpf). Five versions of the Rpf protein exist in TB bacteria. The paper’s unveiling of the molecular structure of Rpf could be crucial to the treatment of TB in the future.

28 Feb 2005

Framework Convention on Tobacco Control (WHO FCTC) entered into force today

The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) entered into force today. This represents an historical moment in public health, as the Treaty gives countries more tools to control tobacco use and save lives.

27 Feb 2005

History of the tracheotomy

The tracheotomy, performed on Pope John Paul II, is an incision made into the windpipe, or trachea, through the front of a person’s neck.

27 Feb 2005

Researchers have identified a protein called HIF-2a, which is important in retina formation

Hoping to prevent blindness in premature babies, UT Southwestern Medical Center researchers have identified a protein that responds to oxygen levels in cells and tissues and also affects the developing eye.

22 Feb 2005

First study to explore the use of biofeedback as a complementary treatment to asthma medication

For the estimated 20.3 million adults and 6.3 million children in the U.S. who suffer from asthma, the primary treatment is the use of medications to help reduce the underlying inflammation in the airways.

22 Feb 2005

Why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa)

Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have found an explanation for why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa).

22 Feb 2005

Air pollution thickens the blood and boosts inflammation

Air pollution, and especially particulate matter, thickens the blood and boosts inflammation, finds experimental research in Occupational and Environmental Medicine.

20 Feb 2005

Deaths from mesothelioma will peak within ten years in the UK

Deaths from mesothelioma, an asbestos-related lung cancer, will peak within ten years in the UK and then fall to a much lower level, according to new figures published in this week's British Journal of Cancer.

17 Feb 2005

$9.8 million grant to research cancer risks from space radiation

NASA awarded a research grant worth more than $9.8 million over five-years to the University of Texas Southwestern Medical Center in Dallas.

16 Feb 2005

Blood tests improve within two weeks of quitting smoking

Long-term smokers who quit may benefit from almost immediate improvements in blood platelet function, which could potentially reduce their risk of heart attacks or strokes caused by blood clots, according to a new study in the Feb. 15, 2005 issue of the Journal of the American College of Cardiology.

16 Feb 2005

Heart repair linked to migraine relief

Migraine headache patients reported the painful attacks eased or even vanished after they underwent procedures to close abnormalities that allow blood to flow between the atria of their hearts, according to the results of two new studies in the current issue of the Journal of the American College of Cardiology.

16 Feb 2005

Clinical trial of newest technology to treat thoracic aortic aneurysms

A clinical trial is underway at the Hospital of the University of Pennsylvania (HUP) to study the safety and effectiveness of an endovascular medical device to treat life-threatening thoracic aortic aneurysms. Ronald Fairman, MD, Chief of Vascular Surgery at HUP, is leading the study at Penn and is one of 35 principal investigators in North America to participate in this landmark trial.

16 Feb 2005

Lungs News and Research

Inflammation is a strong risk factor for cardiovascular disease among rheumatoid arthritis patients

Researchers identify first known mutation to occur in lung cancer patients who have never smoked

Molecule from South American tree Quillaja, helps battle disease

African-Americans receive less aggressive treatment for heart attack than whites

Study describes the first known mutation to occur in lung cancer patients who have never smoked

Nature’s most sophisticated biological weapon

Diesel engines are posing a serious threat to public health

Cells can regenerate without becoming "younger"

Scientists find protein that could unlock the secret to more effective treatment of TB

Framework Convention on Tobacco Control (WHO FCTC) entered into force today

History of the tracheotomy

Researchers have identified a protein called HIF-2a, which is important in retina formation

First study to explore the use of biofeedback as a complementary treatment to asthma medication

Why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa)

Air pollution thickens the blood and boosts inflammation

Deaths from mesothelioma will peak within ten years in the UK

$9.8 million grant to research cancer risks from space radiation

Blood tests improve within two weeks of quitting smoking

Heart repair linked to migraine relief

Clinical trial of newest technology to treat thoracic aortic aneurysms

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News